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The  selective discharge  of lysosome granule  enzymes from human  neutro- 
phils  by certain immunologic  stimuli can be influenced  in opposing directions 
by guanosine 3', 5'-monophosphate  (cyclic  GMP) 1 and  adenosine 3', 5'-mono- 
phosphate  (cyclic AMP)  (1-3).  Similarly,  the immunologic  secretion of lyso- 
somal  enzymes  can  be  enhanced  or  inhibited  by specific  autonomic  neuro- 
hormones  (1-3).  In  fact,  certain  experimental  evidence  suggests  that  the 
enhancing  action of acetylcholine and the inhibitory action of epinephrine on 
enzyme release  from  purified  neutrophils  may be  mediated  by intracellular 
cyclic GMP and cyclic AMP, respectively (4). Expression of the cellular actions 
of certain cholinergic  and adrenergic  agents by cyclic GMP and  cyclic AMP, 
respectively, is  well  documented  (5-10).  Moreover,  convincing  evidence has 
been accumulated by Goldberg and co-workers  (7, 8) that the opposing influ- 
ences of cyclic GMP and cyclic AMP on various cellular processes provides the 
basis for the bidirectional regulation of cell function. 
The principal objective of the present investigation was to determine whether 
cyclic GMP plays a definitive  role in mediating the immunologic  discharge of 
lysosomal enzymes from human neutrophils. Recent reports from this labora- 
tory indicated  that  cyclic GMP  concentrations  in neutrophils  were elevated 
markedly during the lysosomal enzyme discharge  that accompanied cell contact 
with serum-treated zymosan particles  (4).  In order to ascertain whether this 
direct relationship applies to all types of immunologic  stimuli employed to pro- 
voke lysosomal enzyme release the neutrophil levels of cyclic GMP were moni- 
* This study was supported in part by The Schlieder Educational Foundation,  Merck  & 
Co.,  Inc.,  The  Pharmaceutical  Manufacturers  Association  Foundation,  and  U.S.  Public 
Health Service grants no. HL13776 and no. HL14976. 
1Abbrevlations  used  in  this  paper:  agg,  heat-aggregated;  cyclic  AMP,  adenosine  3t,5 t- 
monophosphate;  cyclic  GMP,  guanosine  3',5~-monophosphate;  dibutyryl  cyclic  AMP, 
Nn,O2'-dibutyryl cyclic AMP; Hanks'-glueose, Hanks' balanced salt solution containing 
0.1% (wt/vol) glucose;  RA, rheumatoid arthritic. 
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tored during cell contact with a variety of immune reactants. In addition, the 
influences of  acetylcholine and  epinephrine on  the  time-course of  lysosomal 
enzyme discharge and accumulation of cyclic nucleotides in neutrophils were 
determined. In view of numerous reports illustrating the requirement of cal- 
cium in secretory processes  (11),  the  relationship of  extracellular calcium to 
immunologically  provoked discharge of lysosomal enzymes from, and elevation 
of cyclic GMP levels in, human neutrophils was studied. Further, an assessment 
was  made of  the requirement of extracellular calcium for  the cholinergic en- 
hancement of enzyme secretion and cyclic GMP accumulation. 
The  results  of  this  investigation  suggest  that  intracellular  cyclic  GMP 
mediates the immunologic discharge of lysosome granule contents from human 
neutrophils and that calcium is involved intimately in both the accumulation of 
cyclic GMP and the concomitant secretion of lysosomal contents. Preliminary 
reports of some of the present findings appeared earlier (12,  13). 
Materials and Methods 
Isolation of Human Neutrophils.--Human  neutrophils were isolated from fresh heparinized 
venous blood drawn from healthy volunteers by methods described previously (4). The final 
cell suspension (97-99% neutrophils) was prepared in Hanks' balanced salt solution contain- 
ing 0.1% (wt/vol) glucose (Hanks'-glucose) and diluted to 5 ×  106 cells/ml. In some experi- 
ments cells were suspended in calcium-free Hanks'-glucose. Viability of the neutrophils was 
always greater than 99% (trypan blue or eosin Y exclusion). 
Preparation of Immunologic Reactants.--Untreated, serum-treated and rheumatoid arthritic 
(RA) serum-treated  zymosan particles, and zymosan-treated  serum were prepared by pro- 
cedures described previously (4). Solutions of human IgG, suspensions of heat-aggregated 
(agg) IgG,  suspensions of RA serum-treated  agg IgG, and immobilized RA serum-treated 
agg IgG were prepared and utilized as described (2, 3). 
Conditions of Incubations,  Enzyme  Assays,  and  N~cleotide Measurements.--Neutrophils 
(5 X  10 e in 1.0 ml of Hanks'-glueose) were preincubated and incubated at 37°C in a Dubnoff 
metabolic shaker while agitating at 120 excursions per min. Cells were prelncubated either with 
pharmacologic agents or alone at 37°C for 10 rain before the addition of a given immunologic 
reactant and then further incubated at 37°C for various time intervals. Incubations of cells 
with immobilized reactants were executed as described (3). Mter the incubations the samples 
were processed and measurements of f~-glucuronidase  and lactate  dehydrogenase discharge 
from, and determinations of cyclic GMP and cyclic AMP concentrations in, neutrophils were 
made according to methods outlined previously (4). Recoveries of/3-glucuronidase  and lactate 
dehydrogenase activities from neutrophils and incubation media were determined in each of 
the experiments by procedures described previously (4). Complete recoveries (94-103%) were 
obtained in each experiment. 
Drug Solutions and Sources.--Solutions  of epinephrine contained 0.01% (wt/vol)  sodium 
metabisulfite to prevent spontaneous oxidation and were utilized within 10 min of preparation. 
All other solutions of test agents were prepared fresh and used within 30 rain. The complete 
names of all the chemical agents and drugs, including their salts, used in this study are indi- 
cated below. The following  agents were purchased from Sigma Chemical Co., (St. Louis, Mo.) : 
/-epinephrine  bitartrate,  acetylcholine  chloride, Nn,O2'-dibutyryl cyclic 3r,5'-adenosine 
monophosphate  sodium, cyclic 3',5'-guanosine  monophosphate sodium, ethyleneglycol-bis 
(~-aminoethyl ether) N,N'-tetraacetic acid. L.  J.  IGNARRO  AND  W.  J.  GEORGE  227 
RESULTS 
Effects of Zymosan, A cetylcholine, and Epinephrine on Concentrations of Cyclic 
GMP  and  Cyclic  AMP  in,  and  Discharge of ~-Glucuronidase from,  Human 
Neutrophils.--Neutrophils  were examined for possible changes in the endoge- 
nous  concentrations  or  levels  of  cyclic  GMP  and  cyclic  AMP  during  the 
lysosomal enzyme discharge that results from cell contact with phagocytosable, 
RA serum-treated zymosan particles. Cells (5 X  106) were preincubated in 1.0 
ml of Hanks'-glucose at 37°C for 10 rain before the addition of 4 X  108 zymosan 
particles and then further incubated at 37°C  for 10 min. Under these experi- 
mental conditions phagocytosis of particles occurred and/3-glucuronidase was 
discharged into the extracellular medium (4).  Contact of cells with zymosan 
particles provoked a marked elevation of cyclic GMP levels but no change in 
cyclic AMP levels in neutrophils (Fig. 1). This increase in cyclic GMP  levels 
was  accompanied by  a  concomitant increment  in  /3-glucuronidase  discharge 
from neutrophils (Fig. 2, control data). 
Previous reports from this laboratory indicated that acetylcholine enhanced 
whereas epinephrine inhibited the immunologic discharge of lysosomal enzymes 
from human mixed leukocytes (1) and purified neutrophils (3, 4). However, the 
precise time-course of release of/3-glucuronidase under these conditions was not 
reported. This data is now depicted in Fig. 2 for the purpose of illustrating the 
close temporal relationships between/~-glucuronidase extrusion and neutrophil 
levels of cyclic GMP and cyclic AMP, as  influenced by either  acetylcholine 
(Fig. 3)  or epinephrine (Fig. 4). Acetylcholine provoked' an  increase  in  both 
cyclic GMP levels (Fig. 3)  and/3-glucuronidase discharge (Fig. 2) above those 
produced by zymosan alone, and these two cellular events were closely asso- 
ciated temporally. Neutrophil concentrations of cyclic AMP were not affected 
by either zymosan (Fig. 1) or zymosan plus acetylcholine (Fig. 3). In opposition 
to the actions of acetylcholine, epinephrine inhibited the immunologic release of 
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Fro.  1. Cyclic GMP and cyclic AMP concentrations in human neutrophils during cell 
contact with phagocytosable  zymosan  particles. Neutrophils  were preincubated at 37°C for 10 
rain before addition of RA serum-treated zymosan particles and then further incubated at 
37°C for 1-10 rain. Data represent the Mean 4- SEM of six separate determinations. 228  MECHANISMS  OF  LYSOSOMAL  ENZYME  SECRETION 
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FIG. 2.  Effects of acetylcholine and epinephrine on the immunologic discharge of/~-glu- 
curonidase from human neutrophils. Neutrophils were preincubated with either acetylcholine 
or epinephrine at 37°C for 10 min before addition of RA serum-treated zymosan particles and 
then further incubated at 37°C for 2-30 min. Data represent the Mean 4- SEM of five sepa- 
rate determinations. 
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Fro. 3.  Effects of acetylcholine on cyclic GMP and cyclic AMP concentrations in human 
neutrophils during cell contact with phagocytosable zymosan particles. Neutrophils were pre- 
incubated with 10  -~ M acetylcholine at 37°C for 10 min before addition of RA serum-treated 
zymosan particles and then further incubated at 37°C for 1-10 min. Data represent the Mean 
-4- SEM of three to five separate determinations. 
¢~-glucuronidase from neutrophils (Fig. 2)  and this was associated with a  con- 
comitant elevation of the levels of cyclic AMP  (Fig. 4).  Epinephrine did not 
alter the increase in cyclic GMP levels provoked by the zymosan particles. 
Influence of Autonomic  Neurohormones and Cyclic Nucleotides on the Response 
of Human  Neutrophils  to  Various  Immunologic  Reactants.--Discharge  of  fl- 
glucuronidase  from  human  neutrophils  was  provoked  by  several  different 
immunologic reactants (Table I). Zymosan particles treated with either normal 
or RA serum, agg IgG used by itself or as a  particulate or immobile complex 
with constituents from RA serum, and zymosan-treated normal serum all stimu- 
lated the neutrophils to release ~-glucuronidase into the extracellular medium. L.  J.  IGNARRO  AND  W.  J.  GEORGE  229 
Untreated zymosan, unaltered IgG, and normal serum did not cause enzyme 
release.  Acetylcholine and  cyclic GMP  enhanced  the  discharge of lysosomal 
enzyme from neutrophils  in contact with each of the immune  reactants  that 
elicited enzyme  release by themselves  (Table I). These  two  chemical agents 
did not cause discharge of fl-glucuronidase from cells incubated either alone or in 
the presence of untreated zymosan, unaltered IgG or normal serum. In opposi- 
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FIG. 4.  Effects of epinephrine  on cyclic AMP and cyclic GMP concentrations  in human 
neutrophils during cell contact with phagocytosable zymosan particles. Neutrophils were 
preincubated with 10-rM epinephrine at 37°C for 10 min before addition of RA serum-treated 
zymosan particles and  then  further incubated at 37°C for  1-10  min.  Data represent the 
Mean -4- SEM of three to five separate determinations. 
TABLE I 
Effects of Immunologic Reactants, Autonomic Neurohormones  and Cyclic Nudeotides on 
Discharge of ~-Glucuronidase from Human Neutrophils* 
Experimental condition~ 
Discharge of ~-glucuronidase  (/~g phenolphthalein/18  h/5  X  106 cells)§ 
Dibutyryl 
Control  Acetylcholine  Cyclic GMP  Epinephrine  cyclic AMP 
10  -6 M  10  -7 M  10  -6 M  10  -6 M 
5  X  10~ neutrophils  (N)  3.2  4.  0.2  3.8  4. 
N  +  zymosan (Z)  5.8  4-  0.6  5.7  4. 
N  +  serum-treated  Z  30.2  4.  2.8  62.2 
N  +RAserum-treatedZ  47.6  4-  4.2  98,6  4. 
N  -4- IgG  4.9  4-  0.6  7.1  :k 
N  +  agg IgG  34.4  4.  4.2  56.5 
N  +  RA serum-treated  52.8  i  6.7  127.3  4- 
agg IgG 
N  -4- immobilized RA  66.2  4.  5.5  117.2  4. 
serum-treated  agg IgG 
N  +  serum  1.8  4.  0.1  1.6  :h 
N  +  Z-treated serum  52.4  4.  4.3  98.2  :l: 
0.5  3.1  4-  0.4  4.1  4.4- 0.3  3.5  4- 0.2 
0.8  5.0  4.  0.7  6.2  4.  0.9  6.0  4- 0.7 
9.511  53.2  4-  6.7]1  15.6  4.  2.211  16.7  4.  2.0ll 
12.6[[  86.7  4.  9.4I[  22.3  4.  4,11{  29.8  4.  1-811 
1.4  8.3  4.  1.9  4.7  4- 0,4  5.1  +  0.6 
6.6[[  54.7  4.  7.3[[  20.2  4.  2,51[  20.9  4- 2.2H 
14.4[l  98.2  4.  11.511  29.0  4- 4,111  33.0  4- 3.111 
12.6]]  108.3  i  13.7[[  29.7  -4-  5.4[I  31.8  4.4- 5.2[1 
0.2  2.2  4- 0.t  3.1  4- 0.2  1.7  4.  0.2 
nail  104.8  -4-  8.9[[  29.7  4.  1.611  32.5  4.  3.4[1 
* Data represent  the Mean +  SEM of four-eight separate determinations. 
:~ Neutrophils  were preincubated  with pharmacologic  agents at 37°C for  10 rain before addition  of  the re- 
actants indicated in the left hand column, and then further incubated at 37°C for 15 rain. 
§ Values for total cell enzyme activity ranged from 262 to 330 (Mean +  SEM, 289 -4- 19, based on eight sepa- 
rate determinations). 
H Significantly different (P <  0.01) from corresponding  control. 230  MECHANISMS OF  LYSOSOMAL ENZYME SECRETION 
tion  to  the  actions  of  acetylcholine and  cyclic  GMP,  epinephrine and  the 
dibutyryl analog of cyclic AMP inhibited/3-glucuronidase  release provoked by 
each of the immune reactants (Table I). 
Stimulation of lysosomal enzyme (/3-glucuronidase) discharge from human 
neutrophils by either  immunologic reactants  alone  or  reactants  plus  acetyl- 
choline or  cyclic GMP proceeded  in the  absence of  a  concomitant release  of 
cytoplasmic constituents. Evidence for this is presented in Table II, the data 
from which indicate that cytoplasmic lactate dehydrogenase was not discharged 
by immune reactants or combinations of reactants and other agents. Further, 
the essential lack of uptake of eosin Y  by neutrophils during immunologic dis- 
charge of/3-glucuronidase indicates that cell viability was maintained through- 
out the incubations of cells with reactants and chemical agents (Table II). 
Complete  recoveries  (94-103%)  of  /3-glucuronidase and  lactate  dehydro- 
genase activities from cells and incubation media containing test agents were 
obtained in each experiment. Therefore, all enzyme activities were accounted 
for after all incubations and the presence of immune reactants and test agents 
did not alter enzyme activities appreciably. 
TABLE II 
Effect of Immunologic Reactants,  Acetylcholine  and Cyclic GMP on Viability of 
Human  Neutrophils* 
Discharge of lactate  Neutrophils  with  Experimental condition~  dehydrogenase§  eosin Y uptake 
% 
5 X  106 Neutrophils (N)  0.0028  ±  0.0003  0.8  4-  0.2 
N -b serum-treated zymosan (Z)  0.0026  ±  0.0002  0.7  .4-  0.1 
N -[- RA serum-treated Z  0.0034  -4-  0.0004  1.5  .4-  0.4 
N  +  RA serum-treated Z +  10  -6 M acetylcholine  0,0036  ±  0.0005  1.2  4-  0.3 
N +  RA serum-treated Z +  10  -7 M cyclic GMP  0.0030  .4-  0.0003  1.6  .4-  0.3 
N +  agg IgG  0.0038  .4_  0.0006  0.9  4-  0.2 
N  +  RA serum-treated agg IgG  0.0036  4-  0.0005  1.3  .4-  0.5 
N  +  RA serum-treated agg IgG +  10  -6 M  0.0033  .4-  0.0006  1.4  .4-  0.4 
acetylcholine 
N +  RA serum-treated agg IgG +  10  -r M cyclic  0.0038  -4- 0. 0007  1.6  .4-  0.5 
GMP 
N +  immobilized RA serum-treated agg IgG  0.0029  4-  0. 0004  -- 
N +  immobilized RA serum-treated agg IgG +  0.0037  .4-  0.0008  -- 
10 -6 M acetylcboline 
N +  Z-treated serum  0.0026  ±  0.0003  0.7  .4-  0.2 
N +  Z-treated serum +  10  -6 M acetylcholine  0. 0034 ±  0.0006  0.9  -4-  0.4 
N +  Z-treated serum +  10-TM cyclic GMP  0.0031  4-  0.0004  1.2  -4- 0.5 
* Data represent the Mean ±  SEM of four-six separate determinations. 
~t Neutrophils were preincubated  with pharmacologic agents at 37°C for  10 min before 
addition of immunologic reactants, and then further incubated at 37°C for 15 rain. 
§ Expressed  as A  absorbancy  (366 nm)/min/5  X  106 neutrophils;  value for  total cell 
enzyme activity was 0.141 4- 0.010. L.  J.  IGNARRO  AND  W.  J.  GEORGE  231 
Effects of Various Immunologic Reactants and Autonomic Neurohormones on 
Concentrations of Cyclic GMP and Cyclic AMP in Human Neutrophils.--Each 
of  the  immunologic reactants  that  stimulated lysosomal  enzyme  discharge 
(Table I) also provoked a marked elevation of cyclic GMP levels in neutrophils 
(Table  III).  These  reactants  include zymosan particles  treated  with  either 
normal or RA serum, agg IgG used by itself or as a  particulate  or  immobile 
complex with constituents from RA serum, and zymosan-treated normal serum. 
Cyclic AMP levels were not altered by these reactants. Untreated zymosan, 
unaltered IgG, and normal serum did not elevate the concentrations of cyclic 
GMP in neutrophils. These data are consistent with the failure of the latter 
three substances to provoke the discharge of 3-glucuronidase (Table I). 
Acetylcholine enhanced  the  effects of  the  immune reactants  not  only on 
~-glucuronidase release (Table I) but also on the increase in neutrophil levels of 
cyclic GMP (Table III). In the absence of a suitable reactant, that is, in the 
absence of immunologicaUy induced lysosomal enzyme release,  acetylcholine 
failed to elevate cyclic GMP levels (Table III) or to promote 3-glucuronidase 
discharge  (Table  I).  For  example,  no  cholinergic  stimulation  of  neutrophil 
function  was  observed  when  cells  contacted  untreated  zymosan,  unaltered 
IgG, or normal serum. Thus, once again the discharge of/3-glucuronidase from 
neutrophils was associated with a concomitant increase in the cellular concen- 
trations of cyclic GMP. Neither the reactants alone (Table III) nor reactants 
plus  acetylcholine  (Fig.  4)  affected the  neutr0phil  concentrations of  cyclic 
AMP. 
Epinephrine  inhibited the immunologic discharge of ~-glucuronidase from 
TABLE III 
Effects of Immunologic Reactants and Autonomic Neurohormones  on the Concentrations of Cyclic 
GMP and  Cyclic AMP in Human Neutrophils* 
Experimental conditiont 
Nucleotide concentrations  (pmol/10  s neutrophils) 
Cyclic GMP  Cyclic AMP 
Control  Acetylcholine  Control  Epinephrine 
10  -6 M  10  -6 M 
5 X  10  e Neutrophils (N)  1.34  4- 0.12  1.61  -4-  0.22  7.54  =[=  1.06  13.6  4- 2.32 
N  +  zymosan (Z)  2.10  4- 0.43  1.94  -4- 0.30  8.96  4-  0.92  12.1  =1=  1.96 
N  +  serum-treated Z  12.4  4-  2.65  34.8  4- 4.33§  9.32  4-  1.74  40.5  4- 2.18§ 
N  +  RA serum-treated Z  22.3  4-  3.44  68.5  -4- 8.14§  7.94  4-  0.87  55.1  4-  3.40§ 
N  +  IgG  1.82  4- 0.64  --  6.74  4-  1.02  -- 
N  +  agg IgG  12.7  4-  1.60  30.4  4-  5.73§  9.40  4-  1.39  49.7  4-  4.02§ 
N  +  RA serum-treated agg IgG  41.1  4- 5.32  93.8  4-  10.4§  9.32  4-  1.24  59.8  4- 4.11§ 
N  +  immobilized RA serum-treated agg  56.3  4-  7.13  89.7  4- 6.34§  8.76  4- 2.19  53.3  4-  3.41§ 
IgG 
N  +  serum  0.91  4- 0.17  --  8.06  4-  1.18  -- 
N  +  Z-treated serum  44.8  4-  6.07  98.1  4- 8.80§  7.88  4-  1.62  42.6  4-  5.76§ 
* Data represent  the Mean 4- SEM of three-five separate determinations. 
Neutrophils were preineubated with either acetylcholine or epinephrine at 37°C for 10 rain before addition 
of the reactants indicated in the left hand column,  and then further incubated at 37°C  for 10 rain. 
§ Significantly different (P  <: 0.01)  from corresponding  control. 232  MECHANISMS OF  LYSOSOMAL ENZYME  SECRETION 
neutrophils  (Table I)  but did not lower the elevated levels of cyclic GMP  that 
were associated  with enzyme release  (Fig. 3).  Instead,  epinephrine  provoked a 
concomitant  elevation  of neutrophil  levels of cyclic AMP,  and  these  elevated 
cyclic AMP levels were associated with a  reduction in the release of/~-glucuroni- 
dase  (Table  Ill).  The  enzyme  release  data  illustrated  in  Table  I  have  been 
compared  with  and  related  to  the  nucleotide  data  in  Table  III,  although  the 
incubation  times of the reactions conducted for Table III were  10 min whereas 
those for Table I  (/~-glucuronidase discharge)  were  15 min. The reason for this 
was  that  changes  in  nucleotide  levels  may  have  preceded  the  associated 
changes in enzyme release by up to 5  rain  (preliminary findings). 
Requirement of  Exlracellular  Calcium  for  Both  Immunologic  Discharge  of 
~-Glucuronidase from  and  Elevation  of Cyclic  GMP  in  Human  Neutrophils.-- 
The  requirement  of  extracellular  calcium  for  numerous  secretory  processes  is 
well docttmented  (11).  Likewise,  the  data  in Table  IV  reveal  the  possible  im- 
portance of calcium in mediating the immunologic release of ]ysosomal enzymes 
from  neutrophils.  Basal  levels of  cyclic  GMP  in  neutrophils  were  not  altered 
TABLE IV 
Effects of Calcium  on l~-Glucuronidase Discharge from  and  Cydic  GMP Concentrations 
in Human Neutrophils* 
Calcium, 
Experimental condition~  1.27 m~  Cyclic GMP  Discharge of  (present, +)  concentration  fl-glucuronidase 
(absent, --) 
pmol/lOn cells  ug phenolphthalein/18  h/5 X 10  s cells 
5 X  106 Neutrophils (N)  +  0.72  ±  0.12  4.3  :t:  0.2 
--  1.07  ±  0.19  3.9  ±  0.1 
N  +  serum-treated zymosan (Z)  +  9.81  ±  2.10§  14.6  ~  1.2§ 
--  1.34  ±  0.25  4.8  ±  0.4 
N  +  RA serum-treated Z  +  16.4  ±  1.92§  21.2  -4-  1.8§ 
--  2.53  4-  0.43  5.7  +  0.4 
N  +  RA serum-treated Z +  acetyl-  +  53.5  ±  7.24§  49.5  ±  3.7§ 
choline, 10  -6 M  --  3.10  ±  0.37  6.3  ±  0.8 
N+aggIgG  q-  9.42  ±  1.28§  12.2  +  0.9§ 
-  1.87  -4-  0.33  4.4  ±  0.3 
N  +  agg IgG +  acetylcholine, 10  -6 M  +  28.1  ±  2.20§  38.9  ±  4.0§ 
--  3.02  ±  0.31  6.0  ±  0.7 
N  +  RA serum-treated Z +  EGTA,  +  3.61  ±  0.47  7.4  -4-  0.9 
10 -3  M 
N  +  agg IgG +  EGTA 10  -3 M  +  4.04  -4-  0.33  6.2  :t:  0.8 
N  +  agg IgG +  EGTA, 10  -3 M  +  +  4.47  ±  0.31  8.5  ±  0.6 
aeetylcholine, 10  -~ M 
* Data represent the Mean -4- SEM of four-six separate determinations. 
Neutrophils  were preincubated  with acetylcholine and/or  EGTA at  37°C for  10  rain 
before addition of immunologic reactants, and then further incubated at 37°C for 5 rain. 
§ Significantly different (P <  0.01) from corresponding values in the absence of calcium. L.  J.  IGNARRO AND W.  J.  GEORGE  233 
significantly by eliminating calcium from the extracellular medium (Table IV). 
However, in the absence of extracellular calcium the marked elevation of cyclic 
GMP  levels  as  well  as  the  concomitant  discharge  of  6-glucuronidase,  that 
were associated with contact of neutrophils with both immunologic reactants 
and  calcium,  failed  to occur  (Table  IV).  Further,  in  the  absence  of calcium 
acetylcholine failed to provoke further enzyme release or further elevation of 
cyclic GMP levels. Similar results to those reported above were obtained when 
a  calcium chelating agent,  EGTA, was added  to the incubation  systems con- 
taining calcium (Table IV). 
DISCUSSION 
The experiments  described in this  report were  conducted  in order  to ascertain 
the roles  of cyclic  GMP and calcium  in mediating  or signaling the immunologic 
discharge of lysosomal  enzymes  from human neutrophils. The reasons for ini- 
tiating these studies derived from previous findings  in  this laboratory that 
cyclic GMP and certain cholinergic  agents,  that are known  to elevate  the levels 
of cyclic GMP in various tissues (5-9), enhanced the discharge of lysosomal 
enzymes from neutrophils  during cell contact with particulate agg IgG treated 
with RA  serum (2). Lysosomal  enzyme discharge required the presence of 
extracellular calcium (3). Cyclic  AMP and catecholamines, on the other hand, 
inhibited enzyme release from leukocytes  and purified neutrophils (I, 3). In 
addition to the above studies with intact cells opposing influences  of cyclic 
GMP  (and cholinergic agents) and cyclic AMP (and catecholamines) on the 
osmotic release of enzyme  protein from isolated lysosome fractions were ob- 
served (i0, 14). These data support the original hypothesis  proposed by Gold- 
berg et al. (7) that many  cellular  functions  are affected  in opposite directions, 
and thus regulated, by intracellular cyclic GMP and cyclic  AMP. Moreover, 
cellular concentrations  of both cyclic  nucleotides, and thus cellular functions, 
can be influenced  by autonomic  neurohormones (5, 8). Evidence  for the exist- 
ence of such a bidirectionally  regulated  biologic system in neutrophils  was re- 
ported recently  (4, 15). For example, acetylcholine  enhanced  both  the immuno- 
logic discharge of lysosomal  enzymes  and the accumulation  of neutrophil  cyclic 
GMP whereas epinephrine inhibited enzyme  discharge and promoted the ac- 
cumulation of cyclic  AMP. Our attention was then focused primarily on the 
triggering or signaling  mechanism, namely  cyclic  GMP, by which  immunologic 
stimuli provoke neutrophils to  discharge their lysosomal contents into the 
extracellular environment. 
The time course analysis of nucleotide  levels in neutrophils indicates that 
cyclic GMP levels  are elevated  at i min and peak at 5-I0 rain after  cell contact 
with zymosan  particles. A good  correlation  was obtained  between  the capacities 
of immunologic  reactants to provoke j3-glucuronidase release and to elevate 
neutrophil cyclic  GMP levels without altering cyclic  AMP levels. For example, 
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agg  IgG, and  zymosan-treated  serum  each  triggered  both  ~-glucuronidase 
extrusion  from  and  elevation  of  cyclic  GMP  levels  in  human  neutrophils. 
Further, untreated zymosan, unaltered IgG, and serum failed to provoke either 
enzyme release  or  cyclic  GMP  accumulation. These  findings illustrate  that 
cellular accumulation of cyclic GMP  is associated with the immunologic dis- 
charge  of j3-glucuronidase  from neutrophils  and  suggest  that  cellular  cyclic 
GMP plays a role in mediating lysosomal enzyme secretion. 
A time-course analysis of the effects of acetylcholine and epinephrine on the 
immunologic discharge of ~3-glucuronidase from neutrophils revealed that the 
enhancement and inhibition of enzyme release by acetylcholine and epinephrine, 
respectively, were apparent 2 rain after, and lasted for at least 30 rain after, 
contact  of  cells  with  RA  serum-treated  zymosan  particles.  Similar  results, 
employing only one or two time intervals of incubation, were reported previ- 
ously (4). The purpose of the time course experiments was to relate both times 
of appearance and durations of effects of autonomic neurohormones on enzyme 
discharge to those on cyclic nucleotide accumulation. A close correlation was 
obtained between the  time course of cyclic GMP  accumulation and  that  of 
~3-glucuronidase  discharge  during  contact  of  neutrophils  with  RA  serum- 
treated  zymosan  particles.  Acetylcholine  enhanced  the  magnitude  of  both 
neutrophil  responses  without  altering  the  time  course  relationship.  Simul- 
taneous increases in/3-glucuronidase extrusion and cyclic GMP accumulation 
by acetylcholine were observed during contact of neutrophils with each of the 
immunologic reactants tested. Acetylcholine stimulated neither enzyme release 
nor  cyclic GMP  accumulation in  the  absence  of a  suitable  immunologic re- 
actant. Acetylcholine did not affect cyclic AMP concentrations in neutrophils 
at any time when cyclic GMP levels were elevated. Thus, once again a  close 
association was found between cyclic GMP levels and lysosomal enzyme dis- 
charge, this time under the enhancing influence of acetylcholine. 
Viability of neutrophils was maintained under the experimental conditions 
employed as indicated by the failure of the various immunologic and pharma- 
cologic stimuli either to provoke the discharge of cytoplasmic lactate dehydro- 
genase from cells or to bring about cellular uptake of eosin Y. 
Inhibition of the immunologic discharge of/~-glucuronidase from neutrophils 
by epinephrine was associated, in every instance, with a concomitant accumu- 
lation of cyclic AMP. Epinephrine inhibited the secretion of fl-glucuronidase 
that was provoked by several different immune reactants, and these inhibitory 
effects were  accompanied  by marked  elevations  of  the  neutrophil  levels  of 
cyclic AMP.  Moreover,  the  time course  of accumulation  of cyclic AMP  in 
neutrophils during cell contact with RA serum-treated zymosan particles and 
epinephrine resembled closely that of inhibition of ~3-glucuronidase discharge. 
In the absence of a suitable immunologic stimulus (absence of lysosomal enzyme 
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did not alter  the time-course of accumulation of cyclic  GMP in neutrophils 
during inhibition of immunologic  enzyme discharge  and the accompanying rise 
in cyclic AMP levels. Thus, a close association  was found between cyclic AMP 
levels and inhibition  of the immunologic  secretion of lysosomal enzymes from 
human neutrophils by epinephrine. 
Several reports have illustrated the requirement of extracellular  calcium  for 
the selective discharge  of lysosomal enzymes from granulocytes (3, 15, 16). The 
data in the present study reveal that extracellular  calcium  is required for the 
immunologic  discharge  of /3-glucuronidase  from  purified  human  neutrophils 
regardless  of the type of immunologic  stimulus employed. To illustrate, phago- 
cytosable zymosan particles, agg IgG, and zymosan-treated serum all require 
extracellular  calcium in order to provoke neutrophils to secrete/3-glucuronidase. 
Moreover, the capacities of each of these immune reactants to elevate the levels 
of cyclic GMP in neutrophils  were abolished in  the absence of extracellular 
calcium. Extracellular calcium was required also for the pharmacologic  (acetyl- 
choline)  enhancement of immunologic  release  of lysosomal enzyme from,  and 
the accompanying enhanced accumulation of cyclic GMP in, neutrophils. The 
consistent requirement  of calcium  for both  enzyme release  and  cyclic  GMP 
accumulation provides additional  evidence in support of the hypothesis that 
cyclic GMP is involved closely in mediating the selective discharge of lysosomal 
enzymes from granulocytes. The precise sequence of events and mechanisms by 
which  calcium  and  cyclic  GMP trigger  lysosomal enzyme discharge  are not 
known. However, preliminary studies in this laboratory indicate that immune 
reactants stimulate the uptake of extracellular  calcium  (4~Ca) into, or binding 
of calcium to, neutrophils at 37°C at times (1-5 rain)  when intracellular cyclic 
GMP levels are elevated and/3-glucuronidase  is discharged.  Therefore, intra- 
cellular  calcium  may  be  involved  in  promoting  the  accumulation  of  cyclic 
GMP. Indeed,  calcium  was reported to stimulate the accumulation of cyclic 
GMP in vitro in lung (17) and heart (18) tissue. 
The  experimental  evidence suggests  that  cyclic  GMP  and  calcium  are in- 
volved in mediating, whereas cyclic AMP appears to signal the inhibition of, the 
immunologic  discharge  of lysosomal enzymes from human neutrophils.  Thus, 
the presence in human neutrophils of the biochemical machinery to accumulate 
cyclic GMP and/or cyclic AMP, in response to various extracellular chemical 
stimuli,  provides the granulocytes with the capacity to control the extrusion of 
their  lysosome granule  contents. A  consistent association of cyclic  GMP ac- 
cumulation and/3-glucuronidase  discharge  in neutrophils is observed regardless 
of the type of extracellular immunologic  stimulus. Further, these cell functions, 
both of which require extracellular calcium,  are accentuated by acetylcholine. 
On the other hand, cyclic AMP accumulation is associated closely with inhibi- 
tion  of ~-glucuronidase  release  and  both  events are  elicited  by epinephrine. 
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analog) on the release of ~@ucuronidase from neutrophils during cell contact 
with each of the immunologic reactants were observed. The opposing effects of 
cyclic GMP and cyclic AMP on neutrophil function represent a clear demon- 
stration of the "Yin Yang" concept of bioregulatory mechanisms as proposed 
originally by Goldberg et al. (7), whereby the two nucleotides elicit direct oppo- 
sitional  actions  on  cellular  processes.  Parasympathetic  and  sympathetic 
neurohormones, by virtue of their capacities to influence nucleotide levels in 
neutrophils,  are  also  capable of regulating  the  release of lysosomal enzymes. 
In view of the experimental evidence obtained thus far, we propose that cyclic 
GMP  accumulation,  in  the  presence  of  extracellular  calcium,  mediates  or 
signals the immunologic secretion of lysosomal granule contents from human 
neutrophils and that the potential for cyclic AMP accumulation as well enables 
the granulocytes to exercise a  bidirectional  control of lysosomal enzyme dis- 
charge. 
SUMMARY 
The purpose of this investigation was to elucidate the relationship of cyclic 
GMP  and calcium to the immunologic discharge of lysosomal enzymes from 
purified  human  neutrophils.  Contact  of  neutrophils  with  a  variety  of  im- 
munologic stimuli, including zymosan particles treated with either normal or 
rheumatoid arthritic  (RA)  serum, heat-aggregated (agg) IgG, particulate and 
immobilized agg IgG each treated with RA serum, and zymosan-treated serum, 
provoked  the  discharge  of ~-glucuronidase,  but  not  cytoplasmic lactate  de- 
hydrogenase, and  stimulated  the accumulation of cyclic GMP.  Both enzyme 
release and elevation of cyclic GMP levels required the presence of extracellular 
calcium as neither cellular event proceeded in its absence. Cholinergic enhance- 
ment  of  the  immunologic  secretion  of /~-glucuronidase  from  neutrophils  by 
acetylcholine was associated with a concomitant accumulation of cyclic GMP. 
These actions of acetylcholine on neutrophils did not proceed in the absence of 
extracellular calcium. Whereas the concentrations of cyclic GMP in neutrophils 
were elevated by both immune reactants and a  combination of the latter and 
acetylcholine, cyclic AMP levels remained unaltered. Thus, cyclic GMP, but 
not cyclic AMP,  was associated with the immunologic and pharmacologic dis- 
charge of lysosomal enzymes from neutrophils. Contrariwise, cyclic AMP, but 
not cyclic GMP, was associated with inhibition of lysosomal enzyme release. 
For example,  dibutyryl cyclic AMP  and  epinephrine inhibited  the  release of 
B-glucuronidase  from  neutrophils  that  was  elicited  by  each  of  the  immune 
reactants  tested.  Moreover,  cyclic  AMP  levels  in  the  cells  were  elevated 
markedly in every instance that enzyme discharge was inhibited by epinephrine. 
Epinephrine did not alter the neutrophil concentrations of cyclic GMP at times 
when those of cyclic AMP were elevated. The data in this report constitute 
partial  evidence that  the immunologic discharge of lysosomal enzymes from 
human  neutrophils is mediated or signaled  by intracellular cyclic GMP  and 
that calcium is linked to this stimulation of enzyme secretion. L.  J.  IGNARRO AND W.  J.  GEORGE  237 
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